Cargando…

Treatment of negative symptoms in schizophrenia: a challenge for clinical research

Detalles Bibliográficos
Autores principales:	Schmitt, Andrea, Maurus, Isabel, Falkai, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085889/ https://www.ncbi.nlm.nih.gov/pubmed/36977788 http://dx.doi.org/10.1007/s00406-023-01595-w

Ejemplares similares

Nonpharmacological treatment of dyscognition in schizophrenia: effects  of aerobic exercise 
por: Maurus, Isabel, et al.
Publicado: (2019)

Improvement in daily functioning after aerobic exercise training in schizophrenia is sustained after exercise cessation
por: Falkai, Peter, et al.
Publicado: (2021)

Cellular pathology in the limbic system in schizophrenia
por: Schmitt, Andrea, et al.
Publicado: (2023)

Affected neural networks as basis of disturbed motor function in schizophrenia
por: Schmitt, Andrea, et al.
Publicado: (2020)

The pathophysiology of negative symptoms of schizophrenia: main hypotheses and open challenges
por: Galderisi, Silvana, et al.
Publicado: (2023)

The role of the cerebellum in schizophrenia: from cognition to molecular pathways
por: Yeganeh-Doost, Peyman, et al.
Publicado: (2011)

Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality
por: Schmitt, Andrea, et al.
Publicado: (2018)

EPA guidance on treatment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021)

Biomarkers and neurobiology of schizophrenia
por: Falkai, Peter, et al.
Publicado: (2012)

Associations between aerobic fitness, negative symptoms, cognitive deficits and brain structure in schizophrenia—a cross-sectional study
por: Maurus, Isabel, et al.
Publicado: (2022)

Disturbed Oligodendroglial Maturation Causes Cognitive Dysfunction in Schizophrenia: A New Hypothesis
por: Falkai, Peter, et al.
Publicado: (2023)

Effect of aerobic exercise on cortical thickness in patients with schizophrenia—A dataset
por: Takahashi, Shun, et al.
Publicado: (2020)

Failed regeneration and inflammation in schizophrenia: two sides of the same coin?
por: Falkai, Peter, et al.
Publicado: (2022)

EPA guidance on assessment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021)

Schizophrenia as a disorder of disconnectivity
por: Schmitt, Andrea, et al.
Publicado: (2011)

Post-mortem gene expression of calcium channels Cav1.2 and Cav1.3 in schizophrenia
por: Schmitt, Andrea, et al.
Publicado: (2022)

Depression in Somatic Disorders: Is There a Beneficial Effect of Exercise?
por: Roeh, Astrid, et al.
Publicado: (2019)

Neurobiology of schizophrenia: from outcome to pathophysiological insights
por: Falkai, P., et al.
Publicado: (2012)

Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors
por: Schmitt, Andrea, et al.
Publicado: (2022)

Biological and Clinical Aspects on the Treatment of Schizophrenia and Related Disorders: New Challenges
por: Monreal, José Antonio, et al.
Publicado: (2022)

MDMA for the Treatment of Negative Symptoms in Schizophrenia
por: Arnovitz, Mitchell D., et al.
Publicado: (2022)

The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction
por: Falkai, P., et al.
Publicado: (2011)

Childhood Trauma in Schizophrenia: Current Findings and Research Perspectives
por: Popovic, David, et al.
Publicado: (2019)

Impact of the metabolic syndrome on severe mental disorders
por: Schmitt, Andrea, et al.
Publicado: (2020)

NEGATIVE SYMPTOMS AND NEGATIVE SCHIZOPHRENIA
por: Chaturvedi, S.K., et al.
Publicado: (1984)

S192. EFFECTS OF NICOTINE INTAKE ON NEUROPLASTICITY IN SMOKING AND NON-SMOKING PATIENTS WITH SCHIZOPHRENIA
por: Pross, Benjamin, et al.
Publicado: (2020)

Psychoneurobiology Research and Personalized Treatment of Schizophrenia
por: Sumiyoshi, Tomiki
Publicado: (2021)

Negative symptoms in schizophrenia
por: Mitra, Sayantanava, et al.
Publicado: (2016)

Fitness is positively associated with hippocampal formation subfield volumes in schizophrenia: a multiparametric magnetic resonance imaging study
por: Maurus, Isabel, et al.
Publicado: (2022)

Successful treatment of nightmares may reduce psychotic symptoms in schizophrenia
por: Seeman, Mary V
Publicado: (2018)

Advances in schizophrenia genetics bring new challenges for clinicians and researchers
por: Deshpande, Smita N., et al.
Publicado: (2016)

A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 2: Negative Symptoms in Schizophrenia [Podcast]
por: Racher, Matthew, et al.
Publicado: (2023)

Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm
por: Cerveri, Giancarlo, et al.
Publicado: (2019)

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
por: Correll, Christoph U, et al.
Publicado: (2020)

NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND DEPRESSION
por: Chaturvedi, S.K., et al.
Publicado: (1985)

Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
por: Davidson, Michael, et al.
Publicado: (2022)

Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
por: Vasiliu, O.
Publicado: (2022)

A challenge to the dopamine orthodoxy in schizophrenia?
por: Norman, Trevor R, et al.
Publicado: (2023)

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence
por: Malchow, Berend, et al.
Publicado: (2012)

Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective
por: Bitter, Istvan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0t1btp58ka54cuf1tc80q52216